Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial

Abstract

Background Solid organ transplantation (SOT) is a well-established and life-saving treatment for patients with end-stage organ failure. Organ rejection and infections are among the main complications to SOT and largely determines the clinical outcome. The correct level of immunosuppression is of major importance to prevent these complications. However, it is a consistent observation that in recipients on the same immunosuppressive regimens the clinical outcome varies, and no reliable marker exists to monitor immune function. Methods In a prospective, observational study, we plan to enroll 630 adult patients with a planned organ transplantation at Rigshospitalet, University of Copenhagen, Denmark. Prior to and on different time points up to two years after transplantation we will perform a complete immunological profile on the recipients. This profile will consist of classical descriptive immune phenotyping (flow cytometry and circulating biomarkers) and the functional assay TruCulture®. In TruCulture® whole blood is incubated ex vivo with stimulants imitating bacterial, viral and fungal infections, where after a panel of selected cytokines is quantified. Clinical data from electronic health records will be obtained from the PERSIMUNE (Centre of Excellence for Personalized Medicine of Infections Complications in Immune Deficiency at Rigshospitalet, Copenhagen) data repository, a warehouse of data generated as part of routine care including vital signs, biochemistry, microbiology, pathology as well as medication, demographics, diagnoses, hospital contacts, surgical procedures and mortality. Discussion This will be the first large scale study to determine several aspects of immune function and perform a complete immunological profiling in SOT recipients. It is expected that knowledge generated will provide information to generate prediction models identifying patients at increased risk of infection and/or rejection. If the study is successful, we will subsequently use the generated prediction models to propose personalized immunosuppressive regimens to be tested in future randomized controlled trials. Trial registration This study has been approved by the Regional ethical committee (H-17024315), the Danish Data Protection Agency (RH-2016-47, RH-2015-04, I-Suite 03605) and the Danish National board of Health (3–3013-1060/1). The trial is retrospectively registered at clinicaltrials.gov ( NCT03847285 ) the 20th February 2019.

The Effect of Host Immunity on Predicting the Mortality of Carbapenem-Resistant Organism Infection

“…Currently, clinicians usually assess patients' immune function based on whether patients have underlying diseases, and this has lots of inaccuracy. Lymphocyte function is one of the most important characteristics to reflect host immunity; however, lymphocyte function assessment has not been widely used in clinical practice (Drabe et al, 2019 ; Luo et al, 2019 ).…”

Surgically Used Barrier Membranes Show Distinct Reaction Profiles in an Innovative Human Whole Blood Culture System

“…Besides, other parameters, such as mRNA expression, surface activation-markers, cell viability, morphology, intra-cellular cytokine levels, etc. can be determined by recovery of the cellular components from these cultures as well (33,44,45).…”

Development of Digitalization Road Map for Healthcare Facility Management

“…The accuracy score for the classification performance was 94. and can assist in the early screening of COVID19 positive cases, reducing the burden on healthcare systems [36]. Also, the machine learning (ML) technique was implemented in Denmark to classify patients with chronic lymphocytic leukemia (CLL) who were at risk of infection due to immune dysfunction [23][24].…”